EAM Investors, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 186 filers reported holding ADMA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2024$4,192,243
+2.1%
374,977
-39.7%
0.68%
+6.4%
Q1 2024$4,105,768
+18.6%
622,086
-35.7%
0.64%
-4.2%
Q3 2023$3,462,383
+6.2%
967,146
+9.4%
0.67%
+10.6%
Q2 2023$3,261,377
-4.9%
883,842
-14.7%
0.60%
-10.3%
Q1 2023$3,428,339
-49.5%
1,035,752
-40.8%
0.67%
-52.1%
Q4 2022$6,788,440
+95.7%
1,749,598
+22.6%
1.40%
+86.3%
Q3 2022$3,468,000
+40.3%
1,427,160
+14.3%
0.75%
+25.0%
Q2 2022$2,471,0001,248,1360.60%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Perceptive Advisors 33,169,604$53,072,0000.34%
Clearline Capital LP 922,517$1,476,0000.22%
GSA CAPITAL PARTNERS LLP 860,911$1,377,0000.16%
Prosight Management, LP 115,100$184,0000.12%
Banco BTG Pactual S.A. 92,500$148,0000.10%
Meridian Wealth Management, LLC 164,000$262,0000.03%
Shay Capital LLC 159,614$255,0000.03%
Signature Wealth Management Partners, LLC 10,500$17,0000.02%
XTX Topco Ltd 24,881$40,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 227,469$364,0000.01%
View complete list of ADMA BIOLOGICS INC shareholders